APC2 and CYP1B1 methylation changes in the bone marrow of acute myeloid leukemia patients during chemotherapy

Experimental and Therapeutic Medicine

Volumn 12, Issue 5, 2016, Pages 3047-3052

  Xia, Yongming ^a   Hong, Qingxiao ^a   Chen, Xiaoying ^a   Ye, Huadan ^a   Fang, Lili ^a   Zhou, Annan ^a   Gao, Yuting ^a   Jiang, Danjie ^a   Duan, Shiwei ^a  

^a NINGBO UNIVERSITY   (China)

Author keywords

Acute myeloid leukemia; Adenomatous polyposis col 2; Chemotherapy; Cytochrome P450 family 1 subfamily B polypeptide 1; Promoter methylation

Indexed keywords

ACLACINOMYCIN; ANAPHASE PROMOTING COMPLEX SUBUNIT 2; ARSENIC TRIOXIDE; CYTARABINE; CYTOCHROME P450 1B1; DAUNORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; HOMOHARRINGTONINE; IDARUBICIN; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGE; AGED; ARTICLE; BONE MARROW; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CLINICAL ARTICLE; DNA METHYLATION; FEMALE; GENDER; GENE SEQUENCE; HUMAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY; YOUNG ADULT;

EID: 84991734980     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2016.3719     Document Type: Article

References (16)

1. Boultwood J and Wainscoat JS: Gene silencing by DNA methylation in haematological malignancies. Br J Haematol 138: 3–11, 2007.
2. Powers HR, Bachar M, Savage N, Toscano M and Dainer PM: Azacitidine as salvage therapy for acute myeloid leukemia in a severely ill patient. Hematol Rep 6: 5516, 2014.
3. Galm O, Herman JG and Baylin SB: The fundamental role of epigenetics in hematopoietic malignancies. Blood Rev 20: 1–13, 2006.
4. Rowe JM: The increasing genomic complexity of acute myeloid leukemia. Best Pract Res Clin Haematol 27: 209–213, 2014.
5. Sierra J, Yoshida T, Joazeiro CA and Jones KA: The APC tumor suppressor counteracts beta–catenin activation and H3K4 methylation at Wnt target genes. Genes Dev 20: 586–600, 2006.
6. Griffiths EA, Gore SD, Hooker C, McDevitt MA, Karp JE, Smith BD, Mohammad HP, Ye Y, Herman JG and Carraway HE: Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation. Leuk Lymphoma 51: 1711–1719, 2010.
7. Faiq MA, Ali M, Dada T, Dada R and Saluja D: A novel methodology for enhanced and consistent heterologous expression of unmodified human cytochrome P450 1B1 (CYP1B1). PLoS One 9: e110473, 2014.
8. Nagai F, Hiyoshi Y, Sugimachi K and Tamura HO: Cytochrome P450 (CYP) expression in human myeloblastic and lymphoid cell lines. Biol Pharm Bull 25: 383–385, 2002.
9. DiNardo CD, Gharibyan V, Yang H, Wei Y, Pierce S, Kantarjian HM, Garcia–Manero G and Rytting M: Impact of aberrant DNA methylation patterns including CYP1B1 methylation in adolescents and young adults with acute lymphocytic leukemia. Am J Hematol 88: 784–789, 2013.
10. Fasan A, Alpermann T, Haferlach C, Grossmann V, Roller A, Kohlmann A, Eder C, Kern W, Haferlach T and Schnittger S: Frequency and prognostic impact of CEBPA proximal, distal and core promoter methylation in normal karyotype AML: A study on 623 cases. PLoS One 8: e54365, 2013.
11. Chen C, Wang L, Liao Q, Huang Y, Ye H, Chen F, Xu L, Ye M and Duan S: Hypermethylation of EDNRB promoter contributes to the risk of colorectal cancer. Diagn Pathol 8: 199, 2013.
12. Mokarram P, Zamani M, Kavousipour S, Naghibalhossaini F, Irajie C, Moradi Sarabi M and Hosseini SV: Different patterns of DNA methylation of the two distinct O6–methylguanine–DNA methyltransferase (O6–MGMT) promoter regions in colorectal cancer. Mol Biol Rep 40: 3851–3857, 2013.
13. Zhang L, Shi J, Xu L, Shi B, Hou P and Ji M: Aberrant DNA methylation of drug metabolism and transport genes in nodular goiter. Thyroid Res 4: 15, 2011.
14. Habano W, Gamo T, Sugai T, Otsuka K, Wakabayashi G and Ozawa S: CYP1B1, but not CYP1A1, is downregulated by promoter methylation in colorectal cancers. Int J Oncol 34: 1085–1091, 2009.
15. Widschwendter M, Siegmund KD, M�ller HM, Fiegl H, Marth C, M�ller–Holzner E, Jones PA and Laird PW: Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen. Cancer Res 64: 3807–3813, 2004.
16. Shahab F and Raziq F: Clinical presentations of acute leukemia. J Coll Physicians Surg Pak 24: 472–476, 2014.